🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this study are: to confirm the superiority of TAU-284 ove...
Status
Completed
Location
Reserch site
Start Date
2011-08
Trial ID
NCT01425632
The objectives of this study are: to confirm the superiority of TAU-284 ove...
Status
Completed
Location
Reserch site
Start Date
2013-04
Trial ID
NCT01861522
Treatments Being Tested
The purpose of this study is to assess if BEPREVE (bepotastine besilate oph...
Status
Unknown
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01337557
Treatments Being Tested
Clinical phase I, controlled, non comparative, open, single center study ev...
Status
Completed
Location
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Start Date
2020-09-24
Trial ID
NCT04693429
Treatments Being Tested
An Open-Label, Randomized, 2-sequence, 2-period, Fasted Condition, Single-d...
Status
Completed
Location
H Plus Yangji Hospital
Start Date
2019-04-23
Trial ID
NCT03932435
Treatments Being Tested
The purpose of this study is to study the safety and efficacy of bepotastin...
Status
Completed
Location
ISTA Pharmaceuticals, Inc.
Start Date
2010-06
Trial ID
NCT01174823
Treatments Being Tested
A randomized, open-label, single-dose, 3-period, 6-sequence, 3-way crossove...
Status
Unknown
Location
Inha University Hospital
Start Date
2019-11-08
Trial ID
NCT04097951
Treatments Being Tested
The purpose of this study is to evaluate the drug-drug interaction between ...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02332044
Treatments Being Tested
Study objectives * To compare the safety and pharmacokinetic properties of...
Status
Completed
Location
Yonsei university severance hospital
Start Date
2012-12
Trial ID
NCT01925313
Treatments Being Tested
This study will examine dose ranging characteristics of bepotastine besilat...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2013-01
Trial ID
NCT01753739
Treatments Being Tested